Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $69.08 in the prior trading day, Arcellx Inc (NASDAQ: ACLX) closed at $67.36, down -2.49%. In other words, the price has decreased by -$2.49 from its previous closing price. On the day, 0.57 million shares were traded. ACLX stock price reached its highest trading level at $69.07 during the session, while it also had its lowest trading level at $65.18.
Ratios:
Our goal is to gain a better understanding of ACLX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1017.45. For the most recent quarter (mrq), Quick Ratio is recorded 4.29 and its Current Ratio is at 4.29. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $109.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $70.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $70 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 07 ’25 when Heery Christopher sold 4,230 shares for $75.53 per share. The transaction valued at 319,485 led to the insider holds 28,638 shares of the business.
Heery Christopher sold 3,553 shares of ACLX for $261,831 on Jan 08 ’25. The CHIEF MEDICAL OFFICER now owns 25,085 shares after completing the transaction at $73.69 per share. On Jan 07 ’25, another insider, Gilson Michelle, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 14,012 shares for $75.68 each. As a result, the insider received 1,060,474 and left with 13,579 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 3735475712 and an Enterprise Value of 3133547776. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.38 while its Price-to-Book (P/B) ratio in mrq is 7.53. Its current Enterprise Value per Revenue stands at 20.11 whereas that against EBITDA is -47.988.
Stock Price History:
The Beta on a monthly basis for ACLX is 0.36, which has changed by 0.2617352 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, ACLX has reached a high of $107.37, while it has fallen to a 52-week low of $47.88. The 50-Day Moving Average of the stock is -20.80%, while the 200-Day Moving Average is calculated to be -2.90%.
Shares Statistics:
The stock has traded on average 608.27K shares per day over the past 3-months and 644650 shares per day over the last 10 days, according to various share statistics. A total of 53.99M shares are outstanding, with a floating share count of 40.66M. Insiders hold about 24.82% of the company’s shares, while institutions hold 81.59% stake in the company. Shares short for ACLX as of 1734048000 were 5452275 with a Short Ratio of 9.55, compared to 1731628800 on 4452700. Therefore, it implies a Short% of Shares Outstanding of 5452275 and a Short% of Float of 11.55.
